Youll want patients to get labs done locally (HbA1c, lipid panel, thyroid function) but the visits themselves can be entirely virtual
Now it's year four and my insurance has dropped coverage for Zepbound, so it's $449 from LillyDirect, which is OK at this point in my life
Effervescent tablets that dissolve in water
People who might benefit the most from switching from semaglutide to tirzepatide include those who: Havent lost as much weight as they hoped to on semaglutide, or have run into a weight loss plateau Havent reached their target HbA1c levels on semaglutide, or are hoping for further reductions Have another health condition that only tirzepatide is FDA-approved to treat, such as obstructive sleep apnea If semaglutide hasnt been working well for you, it might be worth switching to tirzepatide
When GLP-1 receptor agonists are used with insulin or sulphonylureas, the risk of hypoglycaemia increases, and dose reductions of these medications may be necessary
This cardiovascular outcomes trial (CVOT) is the longest and largest of the three, following the regulatory precedent set by the SELECT trial for semaglutide, which established cardiovascular risk reduction as a label-worthy endpoint for GLP-1-class agents [5]